StockNews.com began coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the biotechnology company’s stock.
Genocea Biosciences Stock Performance
The company has a market capitalization of $6,000.00, a PE ratio of 0.00 and a beta of 1.61. Genocea Biosciences has a twelve month low of $0.00 and a twelve month high of $0.00. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24.
About Genocea Biosciences
Further Reading
- Five stocks we like better than Genocea Biosciences
- What Are the U.K. Market Holidays? How to Invest and Trade
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- ETF Screener: Uses and Step-by-Step Guide
- AbbVie Stock: A Perfect Dip for Investors to Buy
- What Are Trending Stocks? Trending Stocks Explained
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Genocea Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genocea Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.